US Stock MarketDetailed Quotes
MEIP MEI Pharma
- 3.1200
- +0.0100+0.32%
Close May 21 16:00 ET
- 3.0900
- -0.0300-0.96%
Post 18:43 ET
20.79MMarket Cap0.80P/E (TTM)
3.1600High3.1100Low5.03KVolume3.1600Open3.1100Pre Close15.72KTurnover0.10%Turnover RatioLossP/E (Static)6.66MShares6.909952wk High0.41P/B15.42MFloat Cap2.870052wk Low--Dividend TTM4.94MShs Float12210.9816Historical High--Div YieldTTM1.61%Amplitude2.8700Historical Low3.1260Avg Price1Lot Size
MEI Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.86%-2.93M | 22.53%-11.06M | -25.09%-18.49M | -7.67%-52.48M | 27.10%-11.3M | 28.46%-12.13M | -66.59%-14.27M | -91.45%-14.78M | -52.50%-48.75M | -37.73%-15.5M |
| Net income from continuing operations | 40.88%-9.13M | -207.90%-11.06M | 439.11%56.37M | 41.53%-31.84M | 37.56%-10.03M | -76.94%-15.44M | 184.35%10.25M | 5.06%-16.62M | -31.81%-54.45M | -91.73%-16.06M |
| Operating gains losses | ---- | ---- | ---- | 94.68%-1.1M | --0 | 103.91%500K | 91.10%-486K | 56.82%-1.12M | -14.51%-20.75M | 100.95%67K |
| Depreciation and amortization | -11.34%86K | -7.61%85K | -12.12%87K | 18.40%386K | 15.29%98K | 8.99%97K | 22.67%92K | 28.57%99K | 14.39%326K | 21.43%85K |
| Other non cash items | 7.22%386K | 6.78%378K | 6.59%372K | 57.21%1.43M | 34.07%366K | 92.51%360K | --354K | --349K | --909K | --273K |
| Change In working capital | 253.04%5.06M | 94.84%-1.31M | -8,050.32%-75.69M | -247.83%-24.95M | -294.57%-2.04M | 0.21%1.43M | -507.93%-25.3M | -90.25%952K | -0.40%16.88M | -118.52%-516K |
| -Change in receivables | --0 | --0 | -96.28%85K | 504.51%9.96M | 381.29%4.5M | -34.08%1.12M | -74.23%2.05M | 121.69%2.29M | -115.69%-2.46M | -911.17%-1.6M |
| -Change in prepaid assets | 1,466.56%4.09M | 39.95%-472K | -49.43%530K | -13,804.76%-2.92M | -234.22%-2.88M | 74.11%-299K | 27.49%-786K | 1,397.14%1.05M | 98.04%-21K | 515.47%2.15M |
| -Change in payables and accrued expense | -40.49%1.33M | -161.49%-479K | -904.80%-11.09M | -103.59%-143K | -615.79%-2.06M | -3.36%2.24M | -46.28%779K | -493.55%-1.1M | -36.10%3.98M | -71.98%399K |
| -Change in other current liabilities | -13.21%-360K | -13.46%-354K | -13.03%-347K | -49.23%-1.26M | -62.00%-324K | -68.25%-318K | 31.13%-312K | -10,133.33%-307K | -261.26%-845K | -128.37%-200K |
| -Change in other working capital | --0 | --0 | -6,579.92%-64.86M | -288.52%-30.58M | -0.08%-1.27M | -5.20%-1.31M | -1,508.03%-27.03M | -104.76%-971K | 465.77%16.22M | -1,239.64%-1.27M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 75.86%-2.93M | 22.53%-11.06M | -25.09%-18.49M | -7.67%-52.48M | 27.10%-11.3M | 28.46%-12.13M | -66.59%-14.27M | -91.45%-14.78M | -52.50%-48.75M | -37.73%-15.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -98.78%122K | 132.74%24.52M | -63.91%4.96M | 679.02%53.69M | -3.56%19.4M | -33.85%10.03M | 124.29%10.53M | -8.39%13.74M | -72.11%6.89M | 101.36%20.11M |
| Net PPE purchase and sale | --0 | -109.21%-7K | --0 | 92.69%-35K | 86.60%-41K | 93.86%-7K | 249.02%76K | -687.50%-63K | 32.34%-479K | -3,725.00%-306K |
| Net investment purchase and sale | -98.78%122K | 134.50%24.52M | -64.07%4.96M | 628.87%53.73M | -4.80%19.44M | -34.30%10.03M | 124.14%10.46M | -8.02%13.8M | -71.00%7.37M | 104.26%20.42M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -98.78%122K | 132.74%24.52M | -63.91%4.96M | 679.02%53.69M | -3.56%19.4M | -33.85%10.03M | 124.29%10.53M | -8.39%13.74M | -72.11%6.89M | 101.36%20.11M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -11.66M | 0 | -100.08%-40K | 0 | 0 | 0 | 79.38%-40K | 1,314.39%49.05M | -70.15%20K |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 1,535.16%52.33M | --0 |
| Cash dividends paid | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 72.29%572K | --0 |
| Net other financing activities | ---- | ---- | ---- | 98.96%-40K | --0 | --0 | --0 | 79.38%-40K | -5,909.38%-3.85M | --20K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---11.66M | --0 | -100.08%-40K | --0 | --0 | --0 | 79.38%-40K | 1,314.39%49.05M | -70.15%20K |
| Net cash flow | ||||||||||
| Beginning cash position | -52.61%5.17M | -76.99%3.37M | 7.41%16.91M | 84.24%15.74M | -20.70%8.81M | -13.02%10.92M | -6.20%14.65M | 84.24%15.74M | -30.72%8.54M | 14.03%11.11M |
| Current changes in cash | -33.30%-2.81M | 148.23%1.8M | -1,145.08%-13.53M | -83.80%1.17M | 74.89%8.09M | -46.28%-2.11M | -21.69%-3.74M | -115.36%-1.09M | 289.99%7.2M | 485.02%4.63M |
| End cash Position | -73.13%2.37M | -52.61%5.17M | -76.99%3.37M | 7.41%16.91M | 7.41%16.91M | -20.70%8.81M | -13.02%10.92M | -6.20%14.65M | 84.24%15.74M | 84.24%15.74M |
| Free cash flow | 75.86%-2.93M | 22.14%-11.06M | -24.56%-18.49M | -6.69%-52.52M | 28.29%-11.34M | 28.94%-12.13M | -64.87%-14.21M | -92.07%-14.85M | -50.66%-49.23M | -40.35%-15.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg